squamous cell carcinoma
Palmetto Declines to Cover Molecular Risk Stratification Tests for Cutaneous Squamous Cell Carcinoma
The three other Medicare administrative contractors that participate in the MolDx program aligned their coverage with Palmetto's.
Castle Biosciences Squamous Cell Cancer Test Utility Boosted by New Validation Data, Expert Opinion
Premium
Updated validation data for the DecisionDx-SCC test was published earlier this month, followed by an opinion paper offering consensus guidelines for clinical use.
Polygenic Risk Scores Help Inform Adult Cancer Risk in Childhood Cancer Survivors
Researchers found that cancer-specific PRS and individuals' history of high radiation treatment could help predict development of a handful of adult cancer types.
Cervical Cancer Multiomic Study Uncovers Informative Intratumor Heterogeneity States
With single-cell, spatial, and experimental approaches, researchers defined eight "meta-programs" linked to the tumor immune microenvironment and clinical features.
The company reported that its Barrett's esophagus risk assay saw volumes more than triple in Q3 2023 compared to the same period last year.